Yamauchi, Toshimasa
Kamiya, Hideki
Utsunomiya, Kazunori
Watada, Hirotaka
Kawanami, Daiji
Sato, Junko
Kitada, Munehiro
Koya, Daisuke
Harada, Norio
Shide, Kenichiro
Joo, Erina
Suzuki, Ryo
Bouchi, Ryotaro
Ohta, Yasuharu
Kondo, Tatsuya
Article History
Received: 23 April 2020
First Online: 25 July 2020
Compliance with ethical standards
:
: Toshimasa Yamauchi received honoraria from Astellas Pharma Inc., AstraZeneca K.K., Ono Pharmaceutical Co., Ltd., Sanofi K. K., Takeda Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Novo Nordisk Pharma Ltd., and Novartis Pharma K. K. Author TY received research funding from AstraZeneca K.K., Kowa Company, Ltd., Merck, Daiichi Sankyo Co., Ltd., Sanofi K. K., Boehringer Ingelheim GmbH Japan, and Aero Switch. Author TY received subsidies/donations from Novo Nordisk Pharma Ltd., Ono Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Sanofi K.K., Taisho Pharma Co., Ltd., Kissei Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd., and Daiichi Sankyo Co., Ltd. Author TY belongs to endowed departments by Takeda Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Novo Nordisk Pharma Ltd., Mitsubishi Tanabe Pharma Corporation, Merck, Boehringer Ingelheim GmbH Japan, Kowa Company, Ltd., and Asahi Mutual Life Insurance Company. Hideki Kamiya received honoraria from Sanofi K. K., Novartis Pharma K. K., Ono Pharmaceutical Co., Ltd., MSD K.K., Eli Lilly Japan K.K., Novo Nordisk Pharma Ltd., Astellas Pharma Inc., Mitsubishi Tanabe Pharma Corporation, Sumitomo Dainippon Pharma Co., Ltd., Takeda Pharmaceutical Co., Ltd. Hirotaka Watada received honoraria from Astellas Pharma Inc., AstraZeneca K.K., Nippon Boehringer Ingelheim Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Eli Lilly Japan K.K., MSD K.K., Mitsubishi Tanabe Pharma Corporation, Novo Nordisk Pharma Ltd., Ono Pharmaceutical Co., Ltd., Sanofi K.K., Sanwa Kagaku Kenkyusho Co., Ltd., Kyowa Kirin Co., Ltd., Terumo Corporation, FUJIFILM Pharma, and Takeda Pharmaceutical Co., Ltd. Author HW received research funding from Nippon Boehringer Ingelheim Co., Ltd., Kowa Company, Ltd., Sanofi K.K., Yakult Honsha Co., Ltd., Eli Lilly Japan K.K., Novartis Pharma K. K., and Sanwa Kagaku Kenkyusho Co., Ltd. Author HW received subsidies/donations from Abbott JAPAN Co., Ltd., Astellas Pharma Inc., Nippon Boehringer Ingelheim Co., Ltd., Daiichi Sankyo Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Pfizer Japan Inc., Kissei Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd., Mitsubishi Tanabe Pharma Corporation, MSD K.K., Novo Nordisk Pharma Ltd., Novartis Pharma K. K., Ono Pharmaceutical Co., Ltd., Sanofi K.K., TEIJIN Ltd., and Taisho Pharma Co., Ltd. Author HW belongs to endowed departments by Nippon Boehringer Ingelheim Co., Ltd., Kowa Company, Ltd., MSD K.K., Mitsubishi Tanabe Pharma Corporation, Ono Pharmaceutical Co., Ltd., Sanwa Kagaku Kenkyusho Co., Ltd., Soiken, and Takeda Pharmaceutical Co., Ltd. Daiji Kawanami received honoraria from Takeda Pharmaceutical Co., Ltd., Sanofi K.K., and Novo Nordisk Pharma K.K. Junko Sato received research funding from Sanofi K.K. Daisuke Koya received honoraria from MSD K.K., Astellas Pharma Inc., AstraZeneca K.K., Ono Pharmaceutical Co., Ltd., Taisho Pharma Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Eli Lilly Japan K.K., Nippon Boehringer Ingelheim Co., Ltd., Novo Nordisk Pharma Ltd., Kyowa Kirin Co., Ltd., Taisho Pharmaceutical Co., Ltd., and Sumitomo Dainippon Pharma Co., Ltd. Author DK received research funding from Mitsubishi Tanabe Pharma Corporation, AstraZeneca K.K., and A2 Healthcare Corporation. Author DK received subsidies/donations from Astellas Pharma Inc., Kyowa Kirin Co., Ltd., Kowa Company, Ltd., Sanofi K.K., Johnson & Johnson K.K., Sumitomo Dainippon Pharma Co., Ltd., Takeda Pharmaceutical Co., Ltd., Japan Tobacco Inc. Novo Nordisk Pharma Ltd., Bayer Yakuhin, and Pfizer Japan Inc. Author DK belongs to endowed departments by Nippon Boehringer Ingelheim Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Ono Pharmaceutical Co., Ltd., Taisho Pharma Co., Ltd., and Kyowa Kirin Co., Ltd. Norio Harada received research funding from Japan Diabetes Foundation. Author NH received subsidies/donations from Mitsubishi Tanabe Pharma Corporation, Ono Pharmaceutical Co., Ltd., Sanofi K.K., and MSD K.K. Erina Joo received research funding from Japan Diabetes Foundation. Ryo Suzuki received honoraria from MSD K.K., Novartis Pharma K. K., Takeda Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Nippon Boehringer Ingelheim Co., Ltd., Sanofi K.K., Novo Nordisk Pharma K.K., and Astellas Pharma Inc. Kazunori Utsunomiya, Munehiro Kitada, Kenichiro Shide, Ryotaro Bouchi, Yasuharu Ohta and Tatsuya Kondo declare that they have no conflict of interest. Organizational Conflict of Interest: <i>Co-sponsored seminar</i>: Abbott Diagnostics Medical, Abbott Japan, Abbott Vascular Japan, Aegerion Pharmaceuticals, Ajinomoto, AR Brown, Arkray, Arkray Global Business, Asahi Kasei Pharma, ASKA Pharmaceutical, Astellas Pharma, AstraZeneca, Bayer Yakuhin, Cosmic Corporation, Covidien Japan, Daiichi Sankyo, Eiken Chemical, Eizai, Eli Lilly Japan, Fujifilm Pharma, Fujifilm Toyama Chemical, Fukuda Colin, Fukuda Denshi, Gilead Sciences, Hakubaku, Healthy Network, Hitachi Chemical Diagnostics Systems, Horiba, InBody Japan, Johnson & Johnson, Kaken Pharmaceutical, Kissei Pharmaceutical, Kotobuki Pharmaceutical, Kowa, Kracie Pharmaceutical, Kyowa Kirin, LifeScan Japan, LSI Medience, Medtronic Japan, Mitsubishi Tanabe Pharma, Mochida Pharmaceutical, MSD, Mylan EPD, Nikkiso, Nippon Becton Dickinson, Nippon Boehringer Ingelheim, Nipro, Novartis Pharma, Novo Nordisk Pharma, Ono Pharmaceutical, Otsuka Pharmaceutical, Rizap Group, Roche DC Japan, Sanofi, Santen Pharmaceutical, Sanwa Kagaku Kenkyusho, SRL, Sumitomo Dainippon Pharma, Taisho Pharma, Taisho Pharmaceutical, Takeda Pharmaceutical, Terumo, Unex, Welby. <i>Supporting member</i>: Abbott Japan, Arkray Global Business, Astellas Pharma, AstraZeneca, Bunkodo, Chugai Pharmaceutical, Daiichi Sankyo, EA Pharma, Eizai, Eli Lilly Japan, H+B Life Science, Horiba, Japan Tobacco, Johnson & Johnson, Kaken Pharmaceutical, Kissei Pharmaceutical, Kowa, Kyowa Kirin, LifeScan Japan, Medtronic Japan, Mitsubishi Tanabe Pharma, MSD, Nippon Boehringer Ingelheim, Nipro, Novo Nordisk Pharma, Ono Pharmaceutical, PHC, Roche DC Japan, Sanofi, Sanwa Kagaku Kenkyusho, Sekisui Medical, Shionogi, SRL, Sumitomo Dainippon Pharma, Sysmex, Taisho Pharma, Taisho Pharmaceutical, Takeda Pharmaceutical, Terumo, Tosoh. <i>Research grant</i>: Abbott Japan, Eli Lilly Japan, MSD, Nippon Boehringer Ingelheim, Novo Nordisk Pharma, Sanofi, Takeda Pharmaceutical. <i>Award system</i>: Eli Lilly Japan, Novo Nordisk Pharma, Sanofi.
: The article does not contain any studies with human or animal subjects performed by any of the authors.